Status:
ACTIVE_NOT_RECRUITING
Characterization of Neurocognitive Profiles in Neurodevelopmental Disorders and Epilepsy: a Transdiagnostic Approach
Lead Sponsor:
IRCCS Eugenio Medea
Collaborating Sponsors:
University of Padova
Conditions:
Neurodevelopmental Disorder (Diagnosis)
Epilepsy
Eligibility:
All Genders
6-17 years
Brief Summary
Neurodevelopmental disorders (NDDs) are early-onset conditions affecting personal, social, and academic functioning, with high comorbidity rates and shared neurobiological traits. Traditional diagnost...
Detailed Description
Neurodevelopmental disorders (NDDs) are a heterogeneous group of clinically significant conditions that emerge in early childhood, leading to mild to severe impairments in personal, social, and academ...
Eligibility Criteria
Inclusion
- Age between 6 and 16 years at the time of the study assessment.
- Participant's ability to collaborate in performing computerized cognitive tasks.
- Ability to undergo a neuropsychological assessment in the Italian language
Exclusion
- Presence of organic disorders such as previous ischemic events, cerebral neoplastic elements, or a clinical history including brain surgery.
- Age outside the 6-16 years range.
- Inability to perform computerized cognitive tasks.
- Inability to undergo a neuropsychological assessment in the Italian language.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06877260
Start Date
November 1 2024
End Date
November 1 2027
Last Update
March 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCC E.Medea
Conegliano, Italy/Treviso, Italy, 31015